U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C8H19N
Molecular Weight 129.2432
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTODRINE

SMILES

CC(C)CCCC(C)N

InChI

InChIKey=QNIVIMYXGGFTAK-UHFFFAOYSA-N
InChI=1S/C8H19N/c1-7(2)5-4-6-8(3)9/h7-8H,4-6,9H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C8H19N
Molecular Weight 129.2432
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/6891293 | https://www.ncbi.nlm.nih.gov/pubmed/14881080

Octodrine is a stimulant that is structurally similar to amphetamine and is included in several so-called “pre-workout” and “fat-burning” supplements. Octodrine, has a history of use as a pharmaceutical drug. It was originally developed in the United States as an aerosolized treatment for bronchitis, laryngitis and other conditions Initially approved by the FDA in 1946 as Eskay’s Oralator, this inhaler appeared only in the 1949 edition of the Physicians’ Desk Reference. Octodrine was combined with several other medications, including theophylline, 3-octopamine, and adenosine, in multi-ingredient tablets sold between the early 1960s through the mid-2000s under the trade names Ambredin, Ordinal, Ordinal Retard and Ordinal Forte. Some proponents say octodrine is a safer alternative to other stimulants like ephedra and Dimethylamylamine (DMAA), but there is no scientific information to support this claim. Originally developed in the early 1950’s as a remedy to nasal congestion and as a possible anti-tumor drug, Octodrine has resurfaced as a key ingredient in dietary supplements for its stimulant and thermogenic benefits.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Separation and conductimetric detection of C1-C7 aliphatic monocarboxylic acids and C1-C7 aliphatic monoamines on unfunctionized polymethacrylate resin columns.
2004 Jun 11
Patents

Patents

Sample Use Guides

Maximum daily intake 8.5 g
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:00:36 GMT 2023
Edited
by admin
on Fri Dec 15 16:00:36 GMT 2023
Record UNII
3GQ9E911BI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCTODRINE
INN   MART.   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
SK&F-51
Code English
6-METHYL-2-HEPTYLAMINE
Systematic Name English
NSC-759813
Code English
OCTODRINE [USAN]
Common Name English
HEXYLAMINE, 1,5-DIMETHYL-
Systematic Name English
1,5-Dimethylhexylamine
Systematic Name English
SKF-51
Code English
OxyELITE Pro component DMHA
Common Name English
OCTODRINE [MART.]
Common Name English
octodrine [INN]
Common Name English
1,5-DMHA
Common Name English
OCTODRINE [MI]
Common Name English
SK&F 51
Code English
Octodrine [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29709
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
DSLD 3406 (Number of products:13)
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
Code System Code Type Description
EVMPD
SUB09414MIG
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
INN
2474
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
NCI_THESAURUS
C74107
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
ECHA (EC/EINECS)
208-851-1
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105833
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
RXCUI
236867
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY RxNorm
WIKIPEDIA
Octodrine
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
NSC
759813
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
PUBCHEM
10982
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
DRUG CENTRAL
1978
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
FDA UNII
3GQ9E911BI
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
MERCK INDEX
m8116
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID8046535
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
SMS_ID
100000083866
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
CAS
543-82-8
Created by admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
a very strong psychoactive central nervous system based stimulant. Its first use was to treat nasal congestion, but for many years now it has gained traction and popularity by popping up and being used in different preworkout and fat burning products. Little clinical study.